The Technical Analyst
Select Language :
Stoke Therapeutics Inc [STOK]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Stoke Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Stoke Therapeutics Inc is listed at the  Exchange

-4.73% $13.50

America/New_York / 28 mar 2024 @ 16:00


Stoke Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 625.10 mill
EPS: -2.38
P/E: -5.67
Earnings Date: May 01, 2024
SharesOutstanding: 46.30 mill
Avg Daily Volume: 0.867 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -5.67 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.96x
Company: PE -5.67 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$4.39
(-67.48%) $-9.11
Date: 2024-03-29
Expected Trading Range (DAY)

$ 12.74 - 14.26

( +/- 5.62%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Tulipano Stephen J Sell 13 100 Restricted Stock Units
2024-03-15 Tulipano Stephen J Buy 13 100 Common Stock
2024-03-19 Tulipano Stephen J Sell 4 116 Common Stock
2024-03-15 Ticho Barry Sell 13 100 Restricted Stock Units
2024-03-15 Ticho Barry Buy 13 100 Common Stock
INSIDER POWER
-4.66
Last 99 transactions
Buy: 2 966 256 | Sell: 1 478 633

Forecast: 16:00 - $13.51

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $13.51
Forecast 2: 16:00 - $13.51
Forecast 3: 16:00 - $13.51
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $13.50 (-4.73% )
Volume 4.56 mill
Avg. Vol. 0.867 mill
% of Avg. Vol 525.85 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Stoke Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Stoke Therapeutics Inc

RSI

Intraday RSI14 chart for Stoke Therapeutics Inc

Last 10 Buy & Sell Signals For STOK

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 14 - 15:52buy$5.36N/AActive
Profile picture for
            Stoke Therapeutics Inc

STOK

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy; and STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. It had entered into a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

Last 10 Buy Signals

Date Signal @
BORAUSDMar 29 - 10:30$0.229
WAVESUSDMar 29 - 10:28$3.94
XMRUSDMar 29 - 10:28$134.00
YAKUSDMar 29 - 10:23822.65
STXUSDMar 29 - 10:23$3.58
AUCTIONUSDMar 29 - 10:2326.67
RIOUSDMar 29 - 10:192.44
DAIUSDMar 29 - 10:16$0.999
FLIPUSDMar 29 - 10:055.04
SCNSOLUSDMar 29 - 09:59220.06

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.